Associated Papers
Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation.
Acosta-Medina AA et al.
Blood Advances, 2023
35533258 (PubMed )
Supplement: BLOODA_ADV-2021-006416-mmc1.pdf
Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: an update.
Ardissino G et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 2015
Select a paper to view details